ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

November 27, 2023

  • Improved imaging and advanced tools drive standardized workflow efficiency across multiple specialties
  • Shared common interface and transducers let users move effortlessly between ultrasound systems for a more simplified user experience 

Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23. Globally, ultrasound users are challenged with increased patient volume and staffing shortages – exacerbated by more complex cases. The systems feature new automated tools and a common user interface coupled with transducer compatibility across Philips ultrasound systems, including the recently introduced Compact Ultrasound 5000 Series. These latest advances are demonstrating a positive impact on patient and staff satisfaction with customers worldwide by helping to improve workflow and provide greater scanning efficiency.

“At the University of Washington Medical Center, we have multiple locations where we do a wide range of ultrasounds, from general imaging and obstetrics to abdominal, where our sonographers perform as many as 150-170 ultrasound exams in a typical a day,” said Dr. Manjiri Dighe, MD, Medical Director of Ultrasound and Adjunct Professor of Obstetrics and Gynecology at the University of Washington Department of Radiology, Seattle, USA. “Using the latest advances from Philips Ultrasound like the next generation Flow Viewer and MVI Super Resolution CEUS, it’s easier for me to have increased confidence in my diagnosis and ultimately help my patients get better and faster treatment options. To help us better manage a very heavy throughput of patients, the next generation Auto Scan Assistant also helps the sonographer optimize the image, while reducing the number of keystrokes by more than 50% which has greatly improved our staff satisfaction and the quality of our exams.”

“Our next generation ultrasound systems EPIQ and Affiniti address the challenges healthcare systems face every day in dealing with more patients with more complex conditions while enhancing operational efficiency and reducing costs,” said Jeff Cohen, General Manager of Ultrasound at Philips. “By providing a consistent platform across our systems, and continually improving workflow, we’re able to give clinicians more time to focus on what they do best: caring for their patients.”

Next generation of clinical performance, advanced insights and simplified workflows
New features and major enhancements incorporated in Philips’ latest ultrasound systems driving advanced visualization and efficiency include:

  • Contrast-enhanced ultrasound: EPIQ Elite’s enhanced super-resolution MVI, available only from Philips, offers an improvement of more than 200% in spatial resolution for contrast-enhanced Ultrasound [1] to help provide valuable information about the pattern of blood flow in lesion characterization.
  • Ultra-high frequency transducer: Philips’ new award-winning mL26-8 ultra-high frequency transducer for the EPIQ platform improves spatial resolution by 36% and improves  penetration by 64% improvement [2] over the previous transducers.
  • 3D-like vascular flow advanced imaging: Flow Viewer, Philips’ latest innovation in color flow Doppler imaging, generates a 3D-like image of blood flow in vessels that can enhance decision-making in challenging cases.
  • Fast, quality advanced image acquisition: Philips’ next-generation Auto SCAN Assistant enhances user workflow efficiency to acquire high-quality images with a 54% reduction in button pushes during an exam [3], automatically optimizing the image on a pixel-by-pixel basis.
  • Expanded tele-ultrasound capability: Philips Ultrasound Collaboration Live now allows up to six users to collaborate in real-time during an ultrasound exam, potentially reducing the need for follow-up scans and additional patient travel.

Demonstrations of Philips’ latest EPIQ Elite and Affiniti ultrasound systems, along with live scanning will be available in the Philips Booth #6730 at #RSNA23. Visit Philips at RSNA for more information.

[1] Compared to Philips legacy MVI.
[2] Compared to the predecessor L15-7iO.
[3] When comparing VM10 performance to VM 7 performance.

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978 221 8919
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 70,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.91
-0.34 (-0.15%)
AAPL  267.97
-1.03 (-0.38%)
AMD  258.16
+0.15 (0.06%)
BAC  52.83
-0.04 (-0.09%)
GOOG  271.78
+3.35 (1.25%)
META  751.20
-0.24 (-0.03%)
MSFT  539.06
-3.01 (-0.56%)
NVDA  207.26
+6.23 (3.10%)
ORCL  274.46
-6.37 (-2.27%)
TSLA  458.78
-1.77 (-0.38%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.